Research brief: Women receive hip fracture help from new drug

Millions of women could be protected against life-threatening hip fractures by a once-a-year treatment with a new drug, say UK researchers. The drug zoledronic acid (Aclasta) was tested in a trial of 8,000 women. Those taking Aclasta showed a 70 per cent reduction in fractures of the vertebrate of the spine (NEJM 2007; 356: 1,809–22).

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in